期刊文献+

米力农佐治老年顽固性心力衰竭60例疗效观察 被引量:3

THE CURATIVE EFFECTS OF MILRINONE ON SENILE REFRATORY HEART FAILURE
下载PDF
导出
摘要 目的观察米力农佐治老年顽固性心力衰竭的疗效及其对血浆B型脑钠肽(BNP)浓度的影响。方法将118例老年顽固性心力衰竭患者随机分为治疗组和对照组。治疗组60例,在常规治疗的基础上加用米力农,首剂负荷量50μg/(kg.min),缓慢推注10 min,再以0.5μg/(kg.min)静脉滴注,时间4 h,1次/d。7 d为1疗程。对照组58例,给予常规药物治疗。治疗前后均测其血浆BNP浓度、左室射血分数(LVEF)及左室舒张末径(LVEDD)变化。结果疗效:观察组总有效率95%,对照组为60.34%,观察组高于对照组(χ2=20.62,P<0.01);两组治疗后LVEF及LVEDD比较均有统计学意义(t=10.46,4.61,P<0.01);两组治疗后血浆BNP浓度有统计学意义(t=20.83,P<0.01)。结论米力农短期应用治疗老年顽固性心力衰竭安全有效。 Objective To explore the curative effects of milrinone on senile refratory heart failure (SRHF) and its effects on the concentration of brain natriuretil peptide (BNP) in Type B blood. Methods 118 cases of SRHF were randomly divided the treatment group and the contrast group. The 60 cases in the treatment group were treated with milrinone [ first close of 50μg/(kg· min)] first for 10 minutes and then with milrinone [0.5μg/(kg· min) ] 4 hours, once a day, 7 days as a course in addition to routine treatment. The contrast group was given routine treatment.The left ventricular ejection fraltion (LVEF) and the left ventricular end-diastolic diameter (LVEDD) and the concentration of BNP were examined before and after treatment. Results The total effective rates in the treatment group and the contrast group were 95 % and 60.34 % respectively (χ^2= 20.62, P 〈 0.01). There existed significant differences in LVEF and LVEDD before and after treatment in both groups( P = 10.46,4.61 ; P 〈 0.01). There existed significant differences in BNP between the two groups after treatment ( t = 20.83; P (0.01). Conclusion Milrinone can be used as adjutant to treat seinile refractory heart disease effective and safely.
出处 《山东医学高等专科学校学报》 2008年第5期352-354,共3页 Journal of Shandong Medical College
关键词 老年人 顽固性心力衰竭 米力农 Senile people Refractory heart failure Milrinone
  • 相关文献

参考文献5

  • 1[1]Omejager P.pharmacology of bipyridine phosphodiesterase Ⅲ inhibitors[J].Am Heart,1991,121(6pt2):1939.
  • 2[2]Packer M,Carver JR,Rodeheffer RJ,et al.Effect of oral milrinone on mortality in severe chronic heart failure[J].N EnglMed,1991,325(21):1468.
  • 3[3]Cusick DA,Pfeifer PB,Quigg RJ.Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehosp italization rates in pa2 tientswith severe heart failure[J].Am Cardiol,1998,82 (9):1060.
  • 4[4]Albrecht CA,Giesler GM,Kar B,et al.Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction:a brief case series[J].Tex Heart Inst J,2005,32(2):220-223.
  • 5[5]Bayram M,De Luca L,Massie MB,et al.Reassessment of dobutamine,dopamine,and milrinone in the management of acute heart failure syndromes[J].Am J Cardiol,2005,96(6A):47G-58G.

同被引文献23

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部